Výsledky vyhledávání - "Doddareddy R"

Zobrazeno 1 - 10 of 71 pro vyhledávání: '"Doddareddy R"'

Řazení

Vybrat vše | Vybrané výsledky:

Vybrat výsledek číslo 1 1

Akademický článek

Recommendations for Method Development and Validation of qPCR and dPCR Assays in Support of Cell and Gene Therapy Drug Development.

Autor: Hays A; BioAgilytix Laboratories, Durham, North Carolina, USA. amanda.hays@bioagilytix.com., Wissel M; Eurofins Viracor BioPharma Services, Inc., Lenexa, Kansas, USA., Colletti K; Beam Therapeutics, Cambridge, Massachusetts, USA., Soon R; BioMarin Pharmaceutical Inc., Novato, California, USA., Azadeh M; Ultragenyx Pharmaceutical Inc., Novato, Calfornia, USA., Smith J; Pfizer Inc, Groton, Connecticut, USA., Doddareddy R; Merck & Co., Inc., Rahway, New Jersey, USA., Chalfant M; GSK, Collegeville, Pennsylvania, USA., Adamowicz W; PPD Clinical Research, Thermo Fisher Scientific, Richmond, Virginia, USA., Ramaswamy SS; Eli Lilly and Company, Indianapolis, Indiana, USA., Dholakiya SL; Bristol Myers Squibb, Princeton, New Jersey, USA., Guelman S; Genentech, Inc., South San Francisco, California, USA., Gullick B; BioAgilytix Laboratories, Durham, North Carolina, USA., Durham J; BioAgilytix Laboratories, Boston, Massachusetts, USA., Rennier K; Labcorp Drug Development, Greenfield, Indiana, USA., Nagilla P; Asher Biotherapeutics, Inc., South San Francisco, California, USA., Muruganandham A; BioAgilytix Laboratories, Durham, North Carolina, USA., Diaz M; Eurofins Viracor BioPharma Services, Inc., Lenexa, Kansas, USA., Tierney C; Pfizer Inc, Groton, Connecticut, USA., John K; REGENXBIO Inc., Rockville, Maryland, USA., Valentine J; Regeneron Pharmaceuticals, Tarrytown, New York, USA., Lockman T; PPD Clinical Research, Thermo Fisher Scientific, Richmond, Virginia, USA., Liu HY; Janssen Research & Development, LLC, Spring House, Pennsylvania, USA., Moritz B; Charles River Labs, Reno, Nevada, USA., Ouedraogo JP; Charles River Labs, Senneville, Québec, Canada., Piche MS; Charles River Labs, Senneville, Québec, Canada., Smet M; Sanofi, Ghent, Belgium., Murphy J; Janssen Research & Development, LLC, Spring House, Pennsylvania, USA., Koenig K; Altasciences Preclinical Seattle LLC, Everett, Washington, USA., Zybura A; Labcorp Drug Development, Greenfield, Indiana, USA., Vyhlidal C; KCAS Bioanalytical and Biomarker Services, Shawnee, Kansas, USA., Mercier J; Flowmetric Life Sciences, Inc., Spring House, Pennsylvania, USA., Jani N; BioAgilytix Laboratories, Boston, Massachusetts, USA., Kubista M; Institute of Biotechnology Czech Academy of Sciences, Prague, Czech Republic., Birch D; Altasciences Preclinical Seattle LLC, Everett, Washington, USA., Morse K; Altasciences Preclinical Seattle LLC, Everett, Washington, USA., Johansson O; TATAA Biocenter, Gothenburg, Sweden.

Publikováno v: The AAPS journal [AAPS J] 2024 Feb 05; Vol. 26 (1), pp. 24. Date of Electronic Publication: 2024 Feb 05.

Zobrazit plný text záznamu

Vybrat výsledek číslo 2 2

Akademický článek

Bifunctional molecules targeting SARS-CoV-2 spike and the polymeric Ig receptor display neutralization activity and mucosal enrichment.

Autor: White I; Janssen Biotherapeutics, Janssen R&D LLC, Spring House, PA, USA., Tamot N; Janssen Biotherapeutics, Janssen R&D LLC, Spring House, PA, USA., Doddareddy R; Janssen Biotherapeutics, Janssen R&D LLC, Spring House, PA, USA., Ho J; Janssen Biotherapeutics, Janssen R&D LLC, Spring House, PA, USA., Jiao Q; Janssen Biotherapeutics, Janssen R&D LLC, Spring House, PA, USA., Harvilla PB; Janssen Biotherapeutics, Janssen R&D LLC, Spring House, PA, USA., Yang TY; Janssen Biotherapeutics, Janssen R&D LLC, Spring House, PA, USA., Geist B; Janssen Biotherapeutics, Janssen R&D LLC, Spring House, PA, USA., Borrok MJ; Janssen Biotherapeutics, Janssen R&D LLC, Spring House, PA, USA., Truppo MD; Active Pharmaceutical Ingredient Development, Janssen R&D LLC, Spring House, PA, USA., Ganesan R; Biologics Discovery, Alector, Inc., South San Francisco, CA, USA., Chowdhury P; Janssen Biotherapeutics, Janssen R&D LLC, Spring House, PA, USA., Zwolak A; Janssen Biotherapeutics, Janssen R&D LLC, Spring House, PA, USA.

Publikováno v: MAbs [MAbs] 2021 Jan-Dec; Vol. 13 (1), pp. 1987180.

Zobrazit plný text záznamu

Vybrat výsledek číslo 3 3

Akademický článek

Considerations in the development and validation of real-time quantitative polymerase chain reaction and its application in regulated bioanalysis to characterize the cellular kinetics of CAR-T products in clinical studies.

Autor: Yang TY; Janssen BioTherapeutics, Janssen Research & Development LLC., 1400 McKean Road, Spring House, PA 19477, USA., Doddareddy R; Janssen BioTherapeutics, Janssen Research & Development LLC., 1400 McKean Road, Spring House, PA 19477, USA.

Publikováno v: Bioanalysis [Bioanalysis] 2021 Jan; Vol. 13 (2), pp. 115-128. Date of Electronic Publication: 2020 Dec 23.

Zobrazit plný text záznamu

Vybrat výsledek číslo 4 4

Akademický článek

Generic Reporter Sets for Colorimetric Multiplex dPCR Demonstrated with 6-Plex SNP Quantification Panels.

Autor: Neugebauer, Maximilian^1,2 (AUTHOR) maximilian.neugebauer@hahn-schickard.de, Calabrese, Silvia¹ (AUTHOR) silvia.calabrese@hahn-schickard.de, Müller, Sarah¹ (AUTHOR) muelles5@hs-albsig.de, Truong, Truong-Tu¹ (AUTHOR) tu.truong@hahn-schickard.de, Juelg, Peter^1,2 (AUTHOR) michael.lehnert@hahn-schickard.de, Borst, Nadine^1,2 (AUTHOR), Hutzenlaub, Tobias^1,2 (AUTHOR), Dazert, Eva³ (AUTHOR) eva.dazert-klebsattel@uksh.de, Bubnoff, Nikolas Christian Cornelius von³ (AUTHOR) nikolaschristiancornelius.vonbubnoff@uksh.de, von Stetten, Felix^1,2 (AUTHOR) vstetten@imtek.de, Lehnert, Michael¹ (AUTHOR)

Publikováno v: International Journal of Molecular Sciences. Aug2024, Vol. 25 Issue 16, p8968. 22p.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Vybrat výsledek číslo 5 5

Akademický článek

A generic method for the detection of polyethylene glycol specific IgG and IgM antibodies in human serum.

Autor: Ehlinger C; Biologics Development Sciences, Janssen BioTherapeutics, Janssen R&D, LLC, 1400 McKean Road, PO Box 776, Spring House, PA 19477, USA. Electronic address: cehlinge@its.jnj.com., Spear N; Biologics Development Sciences, Janssen BioTherapeutics, Janssen R&D, LLC, 1400 McKean Road, PO Box 776, Spring House, PA 19477, USA., Doddareddy R; Biologics Development Sciences, Janssen BioTherapeutics, Janssen R&D, LLC, 1400 McKean Road, PO Box 776, Spring House, PA 19477, USA., Shankar G; Biologics Development Sciences, Janssen BioTherapeutics, Janssen R&D, LLC, 1400 McKean Road, PO Box 776, Spring House, PA 19477, USA., Schantz A; Biologics Development Sciences, Janssen BioTherapeutics, Janssen R&D, LLC, 1400 McKean Road, PO Box 776, Spring House, PA 19477, USA.

Publikováno v: Journal of immunological methods [J Immunol Methods] 2019 Nov; Vol. 474, pp. 112669. Date of Electronic Publication: 2019 Oct 12.

Zobrazit plný text záznamu

Vybrat výsledek číslo 6 6

Akademický článek

Development and Translational Application of a Minimal Physiologically Based Pharmacokinetic Model for a Monoclonal Antibody against Interleukin 23 (IL-23) in IL-23-Induced Psoriasis-Like Mice.

Autor: Chen X; Biologics Development Sciences, Janssen BioTherapeutics (X.C., X.J., R.D., B.G., T.M., W.W.) and Global Clinical Pharmacology (H.Z.), Janssen R&D, Spring House, Pennsylvania; and Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, New York (W.J.J.)., Jiang X; Biologics Development Sciences, Janssen BioTherapeutics (X.C., X.J., R.D., B.G., T.M., W.W.) and Global Clinical Pharmacology (H.Z.), Janssen R&D, Spring House, Pennsylvania; and Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, New York (W.J.J.)., Doddareddy R; Biologics Development Sciences, Janssen BioTherapeutics (X.C., X.J., R.D., B.G., T.M., W.W.) and Global Clinical Pharmacology (H.Z.), Janssen R&D, Spring House, Pennsylvania; and Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, New York (W.J.J.)., Geist B; Biologics Development Sciences, Janssen BioTherapeutics (X.C., X.J., R.D., B.G., T.M., W.W.) and Global Clinical Pharmacology (H.Z.), Janssen R&D, Spring House, Pennsylvania; and Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, New York (W.J.J.)., McIntosh T; Biologics Development Sciences, Janssen BioTherapeutics (X.C., X.J., R.D., B.G., T.M., W.W.) and Global Clinical Pharmacology (H.Z.), Janssen R&D, Spring House, Pennsylvania; and Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, New York (W.J.J.)., Jusko WJ; Biologics Development Sciences, Janssen BioTherapeutics (X.C., X.J., R.D., B.G., T.M., W.W.) and Global Clinical Pharmacology (H.Z.), Janssen R&D, Spring House, Pennsylvania; and Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, New York (W.J.J.)., Zhou H; Biologics Development Sciences, Janssen BioTherapeutics (X.C., X.J., R.D., B.G., T.M., W.W.) and Global Clinical Pharmacology (H.Z.), Janssen R&D, Spring House, Pennsylvania; and Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, New York (W.J.J.)., Wang W; Biologics Development Sciences, Janssen BioTherapeutics (X.C., X.J., R.D., B.G., T.M., W.W.) and Global Clinical Pharmacology (H.Z.), Janssen R&D, Spring House, Pennsylvania; and Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, State University of New York at Buffalo, Buffalo, New York (W.J.J.) wwang83@its.jnj.com.

Publikováno v: The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2018 Apr; Vol. 365 (1), pp. 140-155. Date of Electronic Publication: 2018 Feb 02.

Zobrazit plný text záznamu

Vybrat výsledek číslo 7 7

Akademický článek

Deciphering the In Vivo Performance of a Monoclonal Antibody to Neutralize Its Soluble Target at the Site of Action in a Mouse Collagen-Induced Arthritis Model.

Autor: Wang W; Biologics Clinical Pharmacology, Janssen Research & Development, LLC, Spring House, Pennsylvania, USA., McIntosh TS; Biologics Clinical Pharmacology, Janssen Research & Development, LLC, Spring House, Pennsylvania, USA., Jiang X; Biologics Clinical Pharmacology, Janssen Research & Development, LLC, Spring House, Pennsylvania, USA., Doddareddy R; Biologics Clinical Pharmacology, Janssen Research & Development, LLC, Spring House, Pennsylvania, USA., Dell EC; Biologics Clinical Pharmacology, Janssen Research & Development, LLC, Spring House, Pennsylvania, USA., Zhou H; Biologics Clinical Pharmacology, Janssen Research & Development, LLC, Spring House, Pennsylvania, USA. hzhou2@its.jnj.com.; Quantitative Sciences, Janssen Research & Development, LLC, Spring House, Pennsylvania, USA. hzhou2@its.jnj.com.

Publikováno v: Pharmaceutical research [Pharm Res] 2016 Apr; Vol. 33 (4), pp. 1040-9. Date of Electronic Publication: 2015 Dec 30.

Zobrazit plný text záznamu

Vybrat výsledek číslo 8 8

Akademický článek

Mechanistic pharmacokinetic/target engagement/pharmacodynamic (PK/TE/PD) modeling in deciphering interplay between a monoclonal antibody and its soluble target in cynomolgus monkeys.

Autor: Wang W; Biologics Clinical Pharmacology, Janssen R&D, Spring House, Pennsylvania, USA., Wang X, Doddareddy R, Fink D, McIntosh T, Davis HM, Zhou H

Publikováno v: The AAPS journal [AAPS J] 2014 Jan; Vol. 16 (1), pp. 129-39. Date of Electronic Publication: 2013 Nov 28.

Zobrazit plný text záznamu

Vybrat výsledek číslo 9 9

Akademický článek

Drug Regulatory-Compliant Validation of a qPCR Assay for Bioanalysis Studies of a Cell Therapy Product with a Special Focus on Matrix Interferences in a Wide Range of Organ Tissues.